Single Arm, Monocentric, Feasibility Study on an Interactive Virtual Reality Program in 20 Complex In-clinic Palliative Care Patients
This study is not yet recruiting in France. It focuses on Anxiety.
Remote / online
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is not yet recruiting in France. It focuses on Anxiety.
Remote / onlineThis study is not yet recruiting. It focuses on depression and currently lists study information in France.
In FranceThis study is not yet recruiting. It focuses on depression and currently lists study information in France.
Remote / onlineThis study is completed in France, in Germany, in Czech Republic, .... It is testing fremanezumab for Depression.
In FranceThis study is completed in the United States, in France, in Canada, .... It focuses on depression.
In FranceThis study is completed in the United States, in France, in Canada, .... It is testing Aticaprant 10 Milligrams (mg) for Depression.
In FranceThis study was terminated in the United States, in Australia, in France, .... It is testing aticaprant for depression.
In FranceThis study was terminated in the United States, in France, in Belgium, .... It is testing aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms for depression.
In FranceThis study is ongoing in France, in Belgium, in Sweden, .... It is testing aticaprant for depression.
In FranceThis study is completed. It focuses on depression and currently lists study information in France.
In FranceThis study has public registry information. It focuses on depression and currently lists study information in France.
In FranceThis study is active but not recruiting. It focuses on depression and currently lists study information in France.
In FranceHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.